We produced disseminated trichosporonosis in a neutropenic murine model with Trichosporon asahii, which was identified by DNA relatedness analysis. We then assessed the efficacy of granulocyte colony-stimulating factor (G-CSF) (30 to 100 g/kg of body weight per day) and granulocyte-macrophage colony-stimulating factor (GM-CSF) (0.8 to 2 g/kg ⅐ day). The administration of G-CSF either before or after infection improved the survival rate from less than 25% up to 100% (P < 0.05). The effects of G-CSF on organ clearance and histological examinations were most remarkable in the lungs. The levels of tumor necrosis factor alpha (TNF-␣) in bronchoalveolar lavage fluid (BALF) of neutropenic and G-CSF-pretreated mice were 60 ؎ 6 ng/ml and 18 ؎ 6 pg/ml, respectively, at 24 h after infection. Immunohistologically, alveolar macrophages proved to be the main source of TNF-␣ in BALF. GM-CSF increased neutrophil counts less significantly than did G-CSF and increased the lethality (P < 0.05) with a high level of TNF-␣ in BALF. Expecting to inhibit TNF-␣, we administered anti-TNF-␣ intraperitoneally at the dose completely inhibiting TNF-␣ in plasma (2 ؋ 10 4 U), but the TNF-␣ level in BALF and the lethality increased. Though the number of neutrophils at the early stage of infection appeared to be the most critical, the results suggest that other host defense mechanisms, such as TNF-␣ overproduction in the lungs, have an important role in the prognosis of trichosporonosis.